These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9110301

  • 21. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
    Taddei GL, Caldarella A, Raspollini MR, Taddei A, Buccoliero AM.
    Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
    Zhang GJ, Kimijima I, Abe R, Kanno M, Katagata N, Hara K, Watanabe T, Tsuchiya A.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
    [Abstract] [Full Text] [Related]

  • 27. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.
    Anticancer Res; 2002 Dec; 22(4):2493-9. PubMed ID: 12174951
    [Abstract] [Full Text] [Related]

  • 28. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P, Bäckström T, Mählck CG, Ridderheim M, Cajander S.
    Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinoma.
    Sebastiani V, Botti C, Di Tondo U, Visca P, Pizzuti L, Santeusanio G, Alo PL.
    Anticancer Res; 2006 Jul; 26(4B):2983-7. PubMed ID: 16886624
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
    Shiohara S, Shiozawa T, Shimizu M, Toki T, Ishii K, Nikaido T, Fujii S.
    Cancer; 1997 Sep 01; 80(5):908-16. PubMed ID: 9307191
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 34. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Apr 12; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 35. Expression of p53 tumor suppressor gene, oncoprotein c-erbB-2, cellular proliferation and differentiation in malignant and benign pancreatic lesions.
    Jaskiewicz K, Krige JE, Thomson J.
    Anticancer Res; 1994 Apr 12; 14(5A):1919-22. PubMed ID: 7847827
    [Abstract] [Full Text] [Related]

  • 36. Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.
    Vaziri SA, Krumroy LM, Elson P, Budd GT, Darlington G, Myles J, Tubbs RR, Casey G.
    Clin Cancer Res; 2001 Jul 12; 7(7):1937-45. PubMed ID: 11448907
    [Abstract] [Full Text] [Related]

  • 37. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.
    Croat Med J; 2006 Feb 12; 47(1):32-41. PubMed ID: 16489695
    [Abstract] [Full Text] [Related]

  • 38. Osteoclast-like giant cell tumor in mucinous cystadenocarcinoma of the pancreas: an immunohistochemical and molecular analysis.
    Sedivy R, Kalipciyan M, Mazal PR, Wolf B, Wrba F, Karner-Hanusch J, Mühlbacher F, Mader RM.
    Cancer Detect Prev; 2005 Feb 12; 29(1):8-14. PubMed ID: 15734212
    [Abstract] [Full Text] [Related]

  • 39. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
    Frankfurt OS, Robb JA, Sugarbaker EV, Villa L.
    Clin Cancer Res; 1997 Mar 12; 3(3):465-71. PubMed ID: 9815706
    [Abstract] [Full Text] [Related]

  • 40. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma.
    Yeh TS, Jan YY, Chiu CT, Ho YB, Chen TC, Lee KF, Chan KM, Hsu JC, Hwang TL, Chen MF.
    Gut; 2002 Nov 12; 51(5):712-6. PubMed ID: 12377812
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.